알레르기비염에서 면역요법의 현재와 미래

참고문헌 (43)

1. "Direct expenditures for the treatment of allergic rhinoconjunctivitisin 1996 including the contributations of related airway illness", pp.401~7 (1999)
2. "The costs of allergic rhinitis", 2, pp.285~90 (1996)
3. "Rhinitis and asthma:Evidence for respiratory system integration", 111, pp.1171~83 (2003)
4. "Long-term clinical efficacy of grass-pollen immunotherapy", 341, pp.468~75 (1999)
5. "Interleukin 4 production byCD4+ T cells from allergic individuals is modulated by antigen concentrationand antigen-presenting cell type", 181, pp.1081~9 (1995)
6. "Dendritic cells contribute to the development of atopy by an insufficienyin IL-12 production", 109, pp.89~95 (2002)
7. "Immunological changes during specific immunotherapy ofgrass pollen allergy Reduced lymphoproliferative responses to allergenand shift from TH2 to TH1 in T-cell clones specific for Ph1 p 1", pp.1007~15 (1997)
8. "Allergenimmunotherapy decreases interleukin 4 production in CD4+ T cellsfrom allergic individuals", 178, pp.2123~30 (1993)
9. "Mechanisms of immunotherapy", 113, pp.1025~34 (2004)
10. "Role of interleukin10 in spe-cific immunotherapy", 102, pp.98~106 (1998)
11. "Induction of IL-10+CD4+CD25+ Tcells by grass pollen immunotherapy", 111, pp.1255~61 (2003)
12. "Allergen immunotherapy induces a suppressivememory response mediated by IL-10 in a mouse asthma model", 113, pp.1204~10 (2004)
13. "Monitoring allergen immunotherapyof pollen-allergic patients:The ratio of allergen-specificIgG4 to IgG1 correlates with clinical outcome", 29, pp.497~506 (1999)
14. "IgEantibody measurements in ragweed hay fever Relationship to clinicalseverity and the results of immunotherapy", pp.472~82
15. "Fc epsilon receptor I-associated lyn-dependent phosphorylationof Fc gamma receptor IIB during negative regulation ofmast cell activation", 160, pp.1647~58 (1998)
16. "Isotype-associated recognition ofallergen epitopes and its modulation by antigen dose", 84, pp.285~9 (1995)
17. "Immunotherapy with a standardized Dermatophagoides pteronyssinusextract Duration of the efficacy of immunotherapy afterits cessation", pp.430~3 (1996)
18. "and RASTs in thediagnosis of cat allergy", pp.773~9 (1999)
19. "Allergy diagnosis with the radioallergosorbenttest:A comparison with the results of skin and provocation testsin an unselected group of children with asthma and hay fever", 54, pp.209~21 (1974)
20. "Joint Task Force on Practice Parameters American academy of allergy American college of allergy", allergen immu asthma and immu asthma and immu(therapy logy logy), pp.1~40 (2003)
21. "Lack of detectable alterations in immune responsesduring sublingual immunotherapy in children with seasonal allergicrhinoconjunctivitis to grass pollen", 136, pp.134~41 (2005)
22. "Systemic immunological changes induced by administration of grasspollen allergens via the oral mucosa during sublingual immunotherapy", 120, pp.218~24 (1999)
23. "Dose dependenceof immunological response to sublingual immunotherapy", 60, pp.952~6 (2005)
24. "Absorption and distribution kinetics of the majorParietaria judaica allergen administered by noninjectableroutes in healthy human beings", pp.122~9 (1997)
25. "Efficacy of sublingual swallow immunotherapyin children with severe grass pollen allergic symptoms:A doubleblindplacebocontrolled study", 59, pp.498~504 (2004)
26. "Randomizedcontrolled trial of highdose sublingual immunotherapy to treat seasonalallergic rhinitis", 114, pp.831~7 (2004)
27. "Effect of oralimmunotherapy on nasal blockage in experimental allergic rhinitis", 98, pp.380~7 (2005)
28. "Furtherevaluation of local intranasal immunotherapy with aqueous andallergoid grass extracts", 74, pp.694~700 (1984)
29. "Localnasal immunotherapy for Dermatophagoides-induced rhinitis:Efficacyof a powder extract", 91, pp.987~96 (1993)
30. "Pharmahokinetics of radi-olabelled Par j 1 adminsteredintranasally to allergic and healthy subjects", 35, pp.880~3 (2005)
31. "A controlled study of the effectivenessof the Rinkel method of immunotherapy for ragweed pollenhay fever", 65, pp.288~97 (1980)
32. "Successful immunotherapy with T-cell epitope peptides of bee venomphospholipase A2 induces specific T-cell anergy in patients allergicto bee venom", 101, pp.747~54 (1998)
33. "Allergen-specific nasal IgG antibodies induced by vaccinationwith genetically modified allergens are associated with reduced nasalallergen sensitivity", 116, pp.347~54 (2005)
34. "Antigen-immunostimulatoryoligonucleotide conjugates:Mechanisms and applications", 199, pp.217~26 (2004)
35. "Progress in the development of newmethods of immunotherapy Potential pplication of immunostimulatoryDNA-conjugated to allergens for treatment of allergic respiratoryconditions", pp.304~12 (2003)
36. "Recombinant humanized mAb-E25, an anti-IgE mAb", pp.253~9 (2000)
37. "Omalizumab treatment downregulates dendritic cell FcepsilonRI expression", 112, pp.1147~54 (2003)
38. "Omalizumab rapidly decreases nasal allergic response and FcepsilonRIon basophils", 113, pp.297~302 (2004)
39. "The effect of omalizumab on nasal allergic inflammation", 110, pp.68~71 (2002)
40. "and lungdamage in a mouse asthma model"
41. "Interleukin-13:Central mediator of allergic asthma", 282, pp.2258~61 (1998)
42. "Atopy and the human IL-4 receptor alpha chain", 106 (2000)
43. "Oral administration of amite allergen expressed by zucchini yellow mosaic virus in cucurbitspecies downregulates allergen-induced airway inflammation and IgEsynthesis", 113, pp.1079~85 (2004)

관련 논문AI추천